NUVB
Price
$3.23
Change
+$0.01 (+0.31%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
1.1B
42 days until earnings call
TIL
Price
$17.61
Change
-$0.05 (-0.28%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
119.22M
Interact to see
Advertisement

NUVB vs TIL

Header iconNUVB vs TIL Comparison
Open Charts NUVB vs TILBanner chart's image
Nuvation Bio
Price$3.23
Change+$0.01 (+0.31%)
Volume$67.16K
Capitalization1.1B
Instil Bio
Price$17.61
Change-$0.05 (-0.28%)
Volume$700
Capitalization119.22M
NUVB vs TIL Comparison Chart in %
Loading...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NUVB vs. TIL commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVB is a Hold and TIL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (NUVB: $3.22 vs. TIL: $17.66)
Brand notoriety: NUVB and TIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NUVB: 64% vs. TIL: 241%
Market capitalization -- NUVB: $1.1B vs. TIL: $119.22M
NUVB [@Biotechnology] is valued at $1.1B. TIL’s [@Biotechnology] market capitalization is $119.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUVB’s FA Score shows that 0 FA rating(s) are green whileTIL’s FA Score has 1 green FA rating(s).

  • NUVB’s FA Score: 0 green, 5 red.
  • TIL’s FA Score: 1 green, 4 red.
According to our system of comparison, NUVB is a better buy in the long-term than TIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVB’s TA Score shows that 4 TA indicator(s) are bullish while TIL’s TA Score has 5 bullish TA indicator(s).

  • NUVB’s TA Score: 4 bullish, 5 bearish.
  • TIL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TIL is a better buy in the short-term than NUVB.

Price Growth

NUVB (@Biotechnology) experienced а -1.53% price change this week, while TIL (@Biotechnology) price change was -23.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

NUVB is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($1.1B) has a higher market cap than TIL($119M). NUVB YTD gains are higher at: 21.053 vs. TIL (-7.491). TIL has higher annual earnings (EBITDA): -75.66M vs. NUVB (-201.17M). NUVB has more cash in the bank: 608M vs. TIL (91.8M). NUVB has less debt than TIL: NUVB (57.8M) vs TIL (84.9M). NUVB has higher revenues than TIL: NUVB (14.4M) vs TIL (0).
NUVBTILNUVB / TIL
Capitalization1.1B119M926%
EBITDA-201.17M-75.66M266%
Gain YTD21.053-7.491-281%
P/E RatioN/AN/A-
Revenue14.4M0-
Total Cash608M91.8M662%
Total Debt57.8M84.9M68%
FUNDAMENTALS RATINGS
TIL: Fundamental Ratings
TIL
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NUVBTIL
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVSX16.930.09
+0.53%
Lord Abbett Fundamental Equity R4
NWAMX36.930.08
+0.22%
Nationwide BNY Mellon Dyn US Eq Inc K
HSWFX21.63-0.05
-0.23%
Hartford Schroders International Stk F
VLEQX11.23-0.04
-0.35%
Villere Equity
NWZMX22.64-0.33
-1.44%
Nationwide Loomis All Cap Gr R6

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
-1.53%
BEAM - NUVB
48%
Loosely correlated
-2.79%
DNLI - NUVB
47%
Loosely correlated
-2.03%
RCUS - NUVB
45%
Loosely correlated
-1.04%
XNCR - NUVB
45%
Loosely correlated
-0.67%
OCUL - NUVB
44%
Loosely correlated
+0.41%
More

TIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, TIL has been loosely correlated with BNTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TIL jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TIL
1D Price
Change %
TIL100%
-8.83%
BNTX - TIL
49%
Loosely correlated
-0.46%
SMMT - TIL
49%
Loosely correlated
+0.26%
VTYX - TIL
37%
Loosely correlated
-1.06%
NUVB - TIL
36%
Loosely correlated
-1.53%
DSGN - TIL
36%
Loosely correlated
-5.20%
More